Cancer

Chimeric antigen receptor T-cell therapy has transformed the treatment of several blood cancers, yet its success often depends on how...

Breast cancer survivorship is increasingly being defined not by the end of treatment, but by what happens afterward. For many...

Urothelial carcinoma, the most common form of bladder cancer, has entered a new therapeutic era with the arrival of a...

Mass General Brigham researchers have identified two genetic regulators that appear to drive the decline of cancer-fighting T cells in...

Acute myeloid leukemia, or AML, is often described as a single disease, but that label conceals a sprawling collection of...

Hormone receptor–positive early breast cancer has entered an era in which treatment decisions are increasingly shaped by biological risk, rather...

For patients with relapsed or refractory large B-cell lymphoma, reaching a complete remission after salvage therapy is a critical turning...

Sylvester Comprehensive Cancer Center has climbed dramatically in the latest U.S. News & World Report rankings, emerging as Florida’s top...

Acute myeloid leukemia (AML) is a fast-moving blood cancer in which immature myeloid cells accumulate in the bone marrow and...

Firefighters experience measurable changes in proteins circulating through their bodies within a day of battling a fire, according to a...